AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

INTERFERON BETA-1A

15 registrations across 3 African markets— 7 active

Markets with INTERFERON BETA-1A

Recent registrations

Brand / ProductMarketHolderStatusExpires
Rebif 44 Micrograms Solution for Injection**
Solution for injection
🇳🇬NigeriaMerck Pharmaceutical and Life Sciences LimitedactiveOct 2029
REBIF
Solution injectable / 44 µg/0.5 ml
🇹🇳TunisiaMERCK EUROPE B.VexpiredJun 2021
REBIF
Solution injectable / 22 µg/0.5 ml
🇹🇳TunisiaMERCK EUROPE B.VexpiredJun 2021
REBIF 22 µG
Solution injectable / 6 MUI
🇹🇳TunisiaMERCK EUROPE B.VexpiredMar 2021
REBIF
Solution injectable / 12 MUI/0.5 ml
🇹🇳TunisiaMERCK EUROPE B.VexpiredMar 2021
AVONEX
Solution injectable / 30 µg/0.5 ml
🇹🇳TunisiaBIOGEN Idec LtdexpiredAug 2015
REBIF
Solution injectable / 22 µg/0.5 ml
🇹🇳TunisiaMERCK SERONO EUROPE Limited UKexpiredJan 2011
REBIF
Solution injectable / 44 µg/0.5 ml
🇹🇳TunisiaMERCK SERONO EUROPE Limited UKexpiredJan 2011
AVONEX
Solution injectable / 6 MUI
🇹🇳TunisiaBIOGEN Idec LtdexpiredAug 2007
REBIF 22 µG
PREPARATION INJECTABLE
🇲🇦Moroccoactive
REBIF 22 µG
PREPARATION INJECTABLE
🇲🇦Moroccoactive
AVONEX 30µG/0.5ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
REBIF 44 µG
PREPARATION INJECTABLE
🇲🇦Moroccoactive
REBIF 44 µG
PREPARATION INJECTABLE
🇲🇦Moroccoactive
AVONEX 30 µG
SOLUTION INJECTABLE
🇲🇦Moroccoactive

INTERFERON BETA-1A in Africa — Regulatory Overview

INTERFERON BETA-1A is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 7 (47%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.